NEO

#1894
NeoGenomics, Inc. - Common Stock
10.5 2 USD
+3.14%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
10.52
10.52
Faixa anual
4.72
13.74
Mudança diária
+3.14%
Mudança mensal
+16.11%
Mudança em 6 meses
-12.33%
Mudança anual
+42.93%
Fechamento anterior
10.2 0
Open
10.5 2
Mínimo
10.5 2
High
10.5 2
Volume
154
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 1.37 B
  • Employee 2 500
  • Founded 2002
  • CEO Christopher M. Smith
  • Website www.neogenomics.com
  • Headquarter Nevada, United States
  • FIGI BBG000BKH263
  • Industry Diagnósticos e pesquisa
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-13.95
Índice preço/fluxo de caixa
2.07

NeoGenomics, Inc. - Common Stock

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

Notícias